Canada markets closed

HLS Therapeutics Inc. (HLS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
4.7500+0.1000 (+2.15%)
At close: 02:06PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 151.46M
Enterprise Value 241.59M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.77
Price/Book (mrq)1.13
Enterprise Value/Revenue 3.83
Enterprise Value/EBITDA 18.75

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 3-11.93%
S&P500 52-Week Change 322.38%
52 Week High 37.1200
52 Week Low 33.3400
50-Day Moving Average 34.3614
200-Day Moving Average 34.5024

Share Statistics

Avg Vol (3 month) 39.61k
Avg Vol (10 day) 32.16k
Shares Outstanding 531.89M
Implied Shares Outstanding 632.02M
Float 816.36M
% Held by Insiders 10.49%
% Held by Institutions 159.68%
Shares Short (Apr 15, 2024) 473.67k
Short Ratio (Apr 15, 2024) 44.6
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.23%
Shares Short (prior month Mar 15, 2024) 475.13k

Dividends & Splits

Forward Annual Dividend Rate 40.2
Forward Annual Dividend Yield 44.30%
Trailing Annual Dividend Rate 30.08
Trailing Annual Dividend Yield 31.63%
5 Year Average Dividend Yield 41.72
Payout Ratio 40.00%
Dividend Date 3Jun 15, 2023
Ex-Dividend Date 4Apr 27, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -43.65%
Operating Margin (ttm)-6.97%

Management Effectiveness

Return on Assets (ttm)-2.87%
Return on Equity (ttm)-24.69%

Income Statement

Revenue (ttm)63.07M
Revenue Per Share (ttm)1.96
Quarterly Revenue Growth (yoy)1.20%
Gross Profit (ttm)N/A
EBITDA 21.52M
Net Income Avi to Common (ttm)-27.53M
Diluted EPS (ttm)-1.1700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.95M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)87.62M
Total Debt/Equity (mrq)89.69%
Current Ratio (mrq)1.65
Book Value Per Share (mrq)3.06

Cash Flow Statement

Operating Cash Flow (ttm)15.79M
Levered Free Cash Flow (ttm)24.71M